Tanespimycin (KOS-953)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Tanespimycin (KOS-953), covering 2011-06-28 to 2011-06-28. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Tanespimycin (KOS-953) in Patients With Multiple Myeloma in First Relapse [Phase 3]